Endometrial Assessment of Women With Uterine Infection
Endometrial Assessment Women With Infertility Who Will do IUI and ICSI
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Mahmoud Alalfy, PhD
- Phone Number: 01002611058
- Email: mahmoudalalfy@ymail.com
Study Locations
-
-
-
Giza, Egypt
- Recruiting
- Algazeerah and Kasralainy hospital
-
Contact:
- Mahmoud Alalfy, master
- Phone Number: +201002611058
- Email: mahmoudalalfy@ymail.com
-
Contact:
- Ahmed Elgazzar, M.D
- Phone Number: +201014005959
-
Principal Investigator:
- Mahmoud Alalfy, master
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Women with infertility age from 20-40 years
Exclusion Criteria:
- Any factor of infertility
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Hysteroscopic evaluation
Hysteroscopic evaluation Active group : infection Manipulation of endometrium with saline
|
Manipulation of endometrium with saline
Other Names:
|
|
Other: control group
Hysteroscopic evaluation Control group : No infection
|
Manipulation of endometrium with saline
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the number of women who will get pregnant after IUI
Time Frame: within 4 weeks
|
How many women will get pregnant after IUI
|
within 4 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Mahmoud Alalfy, Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Uterine infection
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.